Patients carrying genetic variants of the APOL1 gene, G1 and G2, have an increased risk of developing several forms of kidney disease, including focal segmental glomerulosclerosis (FSGS) and HIV-associated nephropathy (HIVAN) [23,24]. Here, APOL1 is linked to HIV-associated nephropathy.